Literature DB >> 11106535

Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.

S Ohga1, A Nomura, H Takada, K Ihara, K Kawakami, F Yanai, Y Takahata, T Tanaka, N Kasuga, T Hara.   

Abstract

To identify the role of T cells in chronic active Epstein-Barr virus (EBV) infection, EBV and cytokine gene expression was quantified by use of real-time polymerase chain reaction (PCR) among 6 patients who fulfilled the diagnostic criteria for chronic active EBV infection. Four of these patients showed clonal expansion of EBV-infected T cells. Quantitative PCR for EBV DNA in peripheral blood of patients with symptomatic chronic active EBV infection showed higher copy numbers of virus (mean, 1.45 x 10(5) copies/mL) than were seen in blood from patients with infectious mononucleosis (3.08 x 10(3) copies/mL) or with EBV-associated hemophagocytosis (2.95 x 10(4) copies/mL). Fractionated CD3(+) HLA-DR(+) cells from patients with chronic active EBV infection contained higher copy numbers than did CD3(+) HLA-DR(-) cells. Quantitative PCR for cytokines revealed that interferon-gamma, interleukin (IL)-2, IL-10, and transforming growth factor-beta genes were expressed at higher levels in HLA-DR(+) than in HLA-DR(-) T cells. These results suggest that activated T cells in chronic active EBV infection expressed high levels of EBV DNA and both Th1 and Th2 cytokines. EBV-infected T cells may contribute to the unbalanced cytokine profiles of chronic mononucleosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106535     DOI: 10.1086/317653

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

2.  Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking.

Authors:  Mark E Scott; Yifei Ma; Sepideh Farhat; Stephen Shiboski; Anna-Barbara Moscicki
Journal:  J Clin Immunol       Date:  2006-05-16       Impact factor: 8.317

3.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Authors:  Jeffrey I Cohen; Elaine S Jaffe; Janet K Dale; Stefania Pittaluga; Helen E Heslop; Cliona M Rooney; Stephen Gottschalk; Catherine M Bollard; V Koneti Rao; Adriana Marques; Peter D Burbelo; Siu-Ping Turk; Rachael Fulton; Alan S Wayne; Richard F Little; Mitchell S Cairo; Nader K El-Mallawany; Daniel Fowler; Claude Sportes; Michael R Bishop; Wyndham Wilson; Stephen E Straus
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

5.  Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.

Authors:  S Ohga; E Kubo; A Nomura; H Takada; N Suga; E Ishii; A Suminoe; T Inamitsu; A Matsuzaki; N Kasuga; T Hara
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

6.  Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection.

Authors:  S Toyabe; W Harada; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  Cardiovascular complications associated with chronic active Epstein-Barr virus infection.

Authors:  Jun Muneuchi; Shouichi Ohga; Masataka Ishimura; Kazuyuki Ikeda; Kenichiro Yamaguchi; Akihiko Nomura; Hidetoshi Takada; Yasunobu Abe; Toshiro Hara
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

8.  Atypical hypersensitivity to mosquito bites without natural killer cell proliferative disease in an adult patient.

Authors:  Takaaki Konuma; Kaoru Uchimaru; Rieko Sekine; Nobuhiro Ohno; Yasushi Soda; Akira Tomonari; Jun Ooi; Fumitaka Nagamura; Satoshi Takahashi; Tohru Iseki; Naoki Oyaizu; Arinobu Tojo; Shigetaka Asano
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

9.  Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.

Authors:  B Hügle; P Suchowerskyj; H Hellebrand; B Adler; M Borte; U Sack; U Schulte Overberg-Schmidt; N Strnad; J Otto; A Meindl; V Schuster
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

10.  Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.

Authors:  H Kanno; D Watabe; N Shimizu; T Sawai
Journal:  Clin Exp Immunol       Date:  2008-01-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.